T-centric
product
1 mentions
1 recordings
first heard Jun 2026
last heard 15 Jun
↑1 vs the 6 months before
First‑in‑human PD1/PDL1 inhibitor discussed as a case study
Trend
Peak in the week of 15 Jun — 1 mentions across 1 series.
Moments
newest first · ▶ plays the momentUnknownGlobal Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere · Daniel Chen, Founder and CEO at Synthetic Design Lab · 0:26 · 15 Jun
…Daniel Chen is a physician scientist who spent years at the bedside treating melanoma patients, then spent more than a decade at Gentech leading the clinical development of T-centric, the first approved PDL1 inhibitor, from research all the way through the approval around the world.…
All 1 moments